Ustekinumab for Intestinal Behçet's Syndrome With Myelodysplastic Syndrome

Clinical trial NCT07582991 · COMPLETED

Trial details

NCT number: NCT07582991
Sponsor: Liu Tian
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet's Syndrome, Intestinal Type Myelodysplastic Syndrome

Start date: 2024-03-24
Primary completion: 2026-02-23
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.